Yuan Y, Chen X, Zhang L, Wu J, Guo J et al (2016) The roles of exercise in bone remodeling and in prevention and treatment of osteoporosis. Prog Biophys Mol Biol 122:122–130

Article  PubMed  Google Scholar 

Wong SK, Chin K-Y, Ima-Nirwana S (2020) Quercetin as an agent for protecting the bone: a review of the current evidence. Int J Mol Sci 21:6448

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV (2016) Bone turnover markers: emerging tool in the management of osteoporosis. Indian J Endocrinol Metab 20:846–852

Article  PubMed  PubMed Central  Google Scholar 

Eriksen EF (2010) Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 11:219–227

Article  PubMed  PubMed Central  Google Scholar 

Caulfield MP, Reitz RE (2004) Biochemical markers of bone turnover and their utility in osteoporosis. MLO Med Lab Observer 36:34–7

Google Scholar 

Cavalier E, Bergmann P, Bruyère O, Delanaye P, Durnez A et al (2016) The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporos Int 27:2181–2195

Article  CAS  PubMed  Google Scholar 

Hlaing TT, Compston JE (2014) Biochemical markers of bone turnover – uses and limitations. Ann Clin Biochem 51:189–202

Article  PubMed  Google Scholar 

Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG et al (2018) Osteoporosis: a review of treatment options. P t 43:92–104

PubMed  PubMed Central  Google Scholar 

Rahman R, Usman A, Sheikh A, Baig R (2021) Biomarkers for impending risk of osteoporosis in premenopausal women. J College Phys Surg-Pakistan: JCPSP 31:910

Google Scholar 

Ilesanmi-Oyelere BL, Schollum L, Kuhn-Sherlock B, McConnell M, Mros S et al (2019) Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Immun Ageing 16:15

Article  PubMed  PubMed Central  Google Scholar 

Vasikaran S, Eastell R, Bruyere O, Foldes A, Garnero P et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420

Article  CAS  PubMed  Google Scholar 

Neda Sarafrazi EAW, Shepherd JA (2021) Osteoporosis or low bone mass in older adults: United States, 2017–2018. NCHS Data Briefs

Samelson EJ, Demissie S, Cupples LA, Zhang X, Xu H et al (2018) Diabetes and deficits in cortical bone density, microarchitecture, and bone size: framingham HR-pQCT study. J Bone Miner Res 33:54–62

Article  PubMed  Google Scholar 

Haas AV, LeBoff MS (2018) Osteoanabolic agents for osteoporosis. J Endocr Soc 2:922–932

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bandeira L, Lewiecki EM (2022) Anabolic therapy for osteoporosis: update on efficacy and safety. Arch Endocrinol Metabolism 66:707

Article  Google Scholar 

Hassan N, Gregson CL, Tobias JH (2021) Anabolic treatments for osteoporosis in postmenopausal women. Fac Rev 10:44

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hassan JK, Sharrad AK, Sheri FH (2018) Effect of Quercetin supplement on some bone mineralization biomarkers in diabetic type 2 patients. Adv Pharmacol Pharm 6:43–49

Article  CAS  Google Scholar 

Huang Y-Y, Wang Z-H, Deng L-H, Wang H, Zheng Q (2020) Oral administration of quercetin or its derivatives inhibit bone loss in animal model of osteoporosis. Oxidative Med Cellular Longevity. 2020:1–21

Article  Google Scholar 

Niu Y-b, Yang Y-y, Xiao X, Sun Y, Zhou Y-m et al (2020) Quercetin prevents bone loss in hindlimb suspension mice via stanniocalcin 1-mediated inhibition of osteoclastogenesis. Acta Pharmacologica Sinica 41:1476–86

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quercetin. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012.

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395

Article  PubMed  Google Scholar 

Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C (2005) Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing 34:614–619

Article  PubMed  Google Scholar 

Kanis J. Assessment of osteoporosis at the primary health-care level. Technical Report. http: //www shef ac uk/FRAX. 2008.

Wang Z, Pi-Sunyer FX, Kotler DP, Wielopolski L, Withers RT et al (2002) Multicomponent methods: evaluation of new and traditional soft tissue mineral models by in vivo neutron activation analysis. Am J Clin Nutr 76:968–974

Article  CAS  PubMed  Google Scholar 

Densitometry ISFC. 2019 ISCD Official Positions: Adult 2019.

Timed Up & Go (TUG). Centers for Disease Control and Prevention National Center for Injury Prevention and Control 2017.

Cohen J (1988) Statistical power analysis Jbr the behavioral. Lawrence Erlbaum Associates, Sciences Hillsdale (NJ), pp 18–74

Google Scholar 

Preethi Soundarya S, Sanjay V, Haritha Menon A, Dhivya S, Selvamurugan N (2018) Effects of flavonoids incorporated biological macromolecules based scaffolds in bone tissue engineering. Int J Biol Macromol 110:74–87

Article  CAS  PubMed  Google Scholar 

Vakili S, Zal F, Mostafavi-pour Z, Savardashtaki A, Koohpeyma F (2021) Quercetin and vitamin E alleviate ovariectomy-induced osteoporosis by modulating autophagy and apoptosis in rat bone cells. J Cell Physiol 236:3495–3509

Article  CAS  PubMed  Google Scholar 

Derakhshanian H, Ghadbeigi S, Rezaian M, Bahremand A, Javanbakht MH et al (2013) Quercetin improves bone strength in experimental biliary cirrhosis. Hepatol Res 43:394–400

Article  PubMed  Google Scholar 

Civitelli R, Armamento-Villareal R, Napoli N (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 20:843–851

Article  CAS  PubMed  Google Scholar 

Adhikary S, Choudhary D, Ahmad N, Karvande A, Kumar A et al (2018) Dietary flavonoid kaempferol inhibits glucocorticoid-induced bone loss by promoting osteoblast survival. Nutrition 53:64–76

Article  CAS  PubMed  Google Scholar 

Taku K, Melby MK, Kurzer MS, Mizuno S, Watanabe S, Ishimi Y (2010) Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials. Bone 47:413–423

Article  CAS  PubMed  Google Scholar 

Jenkins N, Black M, Paul E, Pasco JA, Kotowicz M, Schneider H-G (2013) Age-related reference intervals for bone turnover markers from an Australian reference population. Bone 55:271–276

Article  CAS  PubMed  Google Scholar 

McLean RR (2009) Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep 7:134–139

Article  PubMed  Google Scholar 

Ismail F, Asif N, Mahdi AA, Islam N (2017) Quercetin-A natural antioxidant from onion may be beneficial in the management of osteoporosis. Natl J Integrated Res Med. 8(2).

Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP et al (2009) Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. Int J Clin Pract 63:19–26

Article  CAS  PubMed  Google Scholar 

Deng T-T, Ding W-Y, Lu X-X, Zhang Q-H, Du J-X et al (2024) Pharmacological and mechanistic aspects of quercetin in osteoporosis. Front Pharmacol. https://doi.org/10.3389/fphar.2024.1338951

Article  PubMed  PubMed Central  Google Scholar 

Kerna NA, Ngwu DC, Akuma OM, Holets HM, Chawla S et al (2024) Quercetin: exploring its unique flavonol properties, bioavailability, safety profile, and therapeutic potential in high-impact medical conditions. Eur J Med Health Res 2:178–198

Article